PHASE 2A PROOF OF CONCEPT PLACEBO CONTROLLED STUDY WITH ORAL ABX464 50MG QD IN ULCERATIVE COLITIS SHOWS ENDOSCOPIC IMPROVEMENT WITH LOSS OF MICROSCOPIC DISEASE ACTIVITY IN MOST ENDOSCOPIC RESPONDERS

Gert De Hertogh ¹ Jean-Marc Steens ² Paul GINESTE ² Julien Santo ³ Severine Vermeire ³
¹ University Hospital Leuven, Leuven, Belgium
² ABIVAX, Paris, France
³ ABIVAX, Montpellier, France

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing